Nigel Birks
Equity Capital Markets Director

Nigel Birks

Nigel has had a distinguished 30-year career in life sciences. He has led the No 1 ranked Extel-rated research team at Dresden Kleinwort, covering EU and US pharma, medtech and biotech companies and executed multiple European and UK capital raises. Following his MBA in management, Nigel worked for Eli Lilly and subsequently ZS Associates, a US life science consultancy. Most recently he advised UK, European and Australian life science companies on capital market transactions, managing institutional investor relationships and leading a team of four specialist sales.

Sector Expertise

Life Sciences